This document provides information on EarWays Medical, a company seeking funding from PARNASA 61 - Biomedical Fund. EarWays has developed earwax removal products for both professionals and home use that use a flexible tip design. The company has over 150 successful uses of its products, is in discussions with distributors and manufacturers, and is working to finalize designs and undergo clinical studies. It is seeking $1 million to fund further product development, clinical studies, business development and marketing.
EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to-use ear care products, designed for clinicians and home use.
EARWAYS MEDICAL is a leading innovator of ear-care solutions. Founded to enhance the well-being of millions of children and adults worldwide, EARWAYS MEDICAL provides easy-to-use ear care products, designed for clinicians and home use.
Australian Banks - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Diversified Financials - Australian Shares ScanShare Trading
Diversified Financials - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Australian Stockmarket Scan - Diversified FinancialsShare Trading
Diversified Financials - Australian Sharemarket Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Scanned 29th April 2010
Ex Assembly - Employee Wellness Programs – Can they Perform in the Spotlight?LearningCafe
Uncertainty, rapid change and a clouded future has created an employee wellness crises. Employee Wellness programs (EWP) which were trotting along before COVID, have been asked to sprint by adapting to the health crises and the ramifications of changes to ways of working including increased work from home.
We discuss the current state of affairs of Employee Wellness and the journey ahead in the continuing crises. The panel also shares best practices and lessons learnt.
This EX Assembly “free-range” discussion focuses on the enterprise implications and its impact on Employee Experience.
With each member of the Rikas investment Group's team possessing a long-term work experience in the fields of healthcare, agriculture, consulting, strategic planning, business development management, sales and marketing, and psychology, we have decided to join our efforts and be useful to many clients facing issues in that fields.
The Group just released their newest corporate brochure.
For more details of the group's activities, please visit the corporate website, http://www.rikas-invest.com
IN NUTS FUND, a Luxembourg based Investment Fund, the pioneer in innovative and global agriculture strategies, focuses on performing a long-term uncorrelated return through investments in nut production, and processing and distribution companies, mainly locally owned and managed.
Australian Banks - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Diversified Financials - Australian Shares ScanShare Trading
Diversified Financials - Australian Shares Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Shares Scanned 17th May 2010
Australian Stockmarket Scan - Diversified FinancialsShare Trading
Diversified Financials - Australian Sharemarket Scan - Quickly browse through the charts to detect patterns and trends. Great for Technical analysis. Charts shown display 100 MA + 50 EMA and a Custom MACD signal.
Scanned 29th April 2010
Ex Assembly - Employee Wellness Programs – Can they Perform in the Spotlight?LearningCafe
Uncertainty, rapid change and a clouded future has created an employee wellness crises. Employee Wellness programs (EWP) which were trotting along before COVID, have been asked to sprint by adapting to the health crises and the ramifications of changes to ways of working including increased work from home.
We discuss the current state of affairs of Employee Wellness and the journey ahead in the continuing crises. The panel also shares best practices and lessons learnt.
This EX Assembly “free-range” discussion focuses on the enterprise implications and its impact on Employee Experience.
With each member of the Rikas investment Group's team possessing a long-term work experience in the fields of healthcare, agriculture, consulting, strategic planning, business development management, sales and marketing, and psychology, we have decided to join our efforts and be useful to many clients facing issues in that fields.
The Group just released their newest corporate brochure.
For more details of the group's activities, please visit the corporate website, http://www.rikas-invest.com
IN NUTS FUND, a Luxembourg based Investment Fund, the pioneer in innovative and global agriculture strategies, focuses on performing a long-term uncorrelated return through investments in nut production, and processing and distribution companies, mainly locally owned and managed.
Grace Century is a research group representing accredited investors, 500+ strong, with a wealth of experience, contacts and insight.
We filter through the 100’s of projects that are brought to us each year and find the true “game changers” that are poised to be the next leader of a new industry or change an existing industry. This usually results in one or two very special projects for consideration a year.
As a group, we are able to negotiate for our members projects obtained from a position of strength, gaining the best possible arrangement, and gaining continuous involvement and oversight as the project develops.
Through this continuous involvement from the top, utilizing our networks in all aspects of business, and offering on-going information, we believe Grace Century gives its members a project with dramatically reduced risk while increasing the probability of success.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. ABOUT US
EarWays Medical is offering solutions for earwax removal and management treatments
both for professional ear care givers and home care users.
The patent pending technology of EarWays Medical uses a flexible tip design to facilitate
ear wax collection with minimal risk. It is easy to use, self-explanatory, and disposable.
The product allows the user to safely remove ear wax from the ear in a safe and effective
manner. It was designed in consultation with ear, nose and throat doctors to ensure safety and
minimize risk to the user.
EarWays Pro and EarWays Homecare are available in several spiral head diameters for
adults, children and toddlers.
PARNASA 61 – Biomedical Fund 2017
3. MISSION
To set the new gold standard in earwax management and
removal, by introducing innovative products for professional
ear care givers and homecare users.
2017PARNASA 61 – Biomedical Fund
4. EarWays Pro - final design stage
EarWays Homecare - advanced design stage
National phase (US, EU, CH, JP, IL) submitted
CE approved
US trade name
Over 150 successful cases
In discussions with Japanese lead player
Signed commitments from Belgian and Israeli distributors
Recruited Scientific Advisory Board
In discussion with hearing aids manufacturer, hearing institutions
Commencing Clinical Study.
2017
HIGHLIGHTS
PARNASA 61 – Biomedical Fund
5. MARKET ANALYSIS
2017PARNASA 61 – Biomedical Fund
USA EarWays
Pro
USA EarWays
Homecare
Europe EarWays
Pro
Europe EarWays
Homecare
$142M
$926M
$389M
$1.667M
Total Addressable Market EU & USA $3B
USA EarWays Pro
USA EarWays Homecare
Europe EarWays Pro
Europe EarWays Homecare
US EUROPE
6. 2017PARNASA 61 – Biomedical Fund
EarWays Pro EarWays Homecare
US TARGET MARKET
7. 10
8
6
4
2
0
2018 2019 2020 2021 2022
FORECASTING
2017
Revenue forecast in US $M
PARNASA 61 – Biomedical Fund
8. $1,700 M
$1,275 M
$850 M
$425 M
$0 M
USA
EarWays Pro
USA EarWays
Homecare
Europe
EarWays Pro
Europe EarWays
Homecare
$3 Billion Total addressable market of Europe
and USA
Entered into partnerships for enhanced distribution
and marketing network
ADDITIONAL INSIGHTS
2017PARNASA 61 – Biomedical Fund
9. Raised to date:
$50K Tnufa - Israeli Office of
Chief Scientist
$100K Self Funding
$100K Angel Investor
$250K Parnasa VC
FUNDINGSEEKING
2017PARNASA 61 – Biomedical Fund
Manufacturing for mass production,
expanded clinical studies, business
development, sales & marketing
$1M
Partnerships; Joint
Ventures; Distribution
Networks
USE OF PROCEEDS
10. Reached
16: EarWays Pro - Finalize design and Clinical Study in Israel
Q1 17:EarWays Pro - Design for Manufacturing and initial sale
Upcoming
Q4 17: EarWays Pro - Limited Market Release EU & US,
EarWays Medical Consumer – Finalize Design for clinical study
Q2 18: EarWays Pro - Launch in EU
EarWays Pro - Limited Market release in the US.
MILESTONES
2017PARNASA 61 – Biomedical Fund
11. THE TEAM
Dr. Kraitzer is an entrepreneur, biomaterials specialist, and
an inventor in the field of medical device.
He has proven record in management and problem solving
skills in both scientific and industrial environments with
extensively experienced engineering capabilities and broad
experience in medical device technology, product
development, manufacturing and commercialization in view
of regulatory requirements (US and European).
2017PARNASA 61 – Biomedical Fund
Dr. Amir Kraitzer
Founder & CTO
12. THE TEAM
2017
Since 2008, Yael has been advising and coaching startups
on their strategy, business development, and fundraising.
She has extensive international experience and expertise
within the startup ecosystem, and holds deep knowledge
of the life science industry.
She managed marketing for a US based startup, giving
her the experience needed to head up the Startup Center
at the Israeli Export Institute and create a technology
matchmaking position at Ernst & Young Israel.
PARNASA 61 – Biomedical Fund
Yael Karlin
Managing Director
13. Offers safe and
effective solution
for home care
users
Has
successfully
covered over
150 cases
Provides high
efficiency even in
hard and complex
cases
Single use device
offering maximal
protection of ear
hygiene
2017
ADVANTAGES
PARNASA 61 – Biomedical Fund
14. Tnufa Israeli Self Funding Angel Investor Parnasa (VC)
$250 K
$200 K
$150 K
$100 K
$50 K
$0 K
Fundingsources
Uses of Proceeds
Manufacturing for mass production
Expanded clinical studies, business development, sales and marketing
2017
FUNDING SOURCES
PARNASA 61 – Biomedical Fund
15. An Israeli company managed by Parnasa Nihul Basad Ltd, seeking to raise $1.715
million in equity capitalization.
The Company’s investment objective is to generate superior long-term capital
appreciation through private equity investments in early-stage private companies
primarily based in the United States and Israel.
The Investment Manager is controlled by Eliezer Gross who holds a controlling interest
of management shares of the Company. The Investment Manager will be responsible
for the Company’s investment strategy and the management of the Company. He will
perform all day-to-day investment and asset management functions for the Company,
subject to the supervision and direction of the Company’s Board of Directors.
The Company has been formed to make seed and early-stage investments in the
common stock and preferred stock of start-up technology ventures located in Israel.
2017
PARNASA 61 - Biomedical Fund
PARNASA 61 – Biomedical Fund
16. INVESTMENT STRATEGYThe Company intends to invest substantially all of the proceeds of the sale of Shares
offered in the existing portfolio.
In addition, the Company may invest (or reinvest proceeds of exited investments) in
one or more other start-up technology ventures from time to time subject to the
availability of resources.
The Company intends to have multiple closings, so that any money that comes in
could immediately be used by the Company even if it is below the total amount of
capital sought to be raised pursuant to the official offering.
2017
INVESTMENT STRATEGY
PARNASA 61 – Biomedical Fund
17. The Company’ s existence is perpetual and therefore
dissolution and/or distribution of all or part of the
Company’s assets are not expected at any
time in the future.
6000 shares = $10,625.
Fund will bear all costs and expenses.
The Company is being treated as a corporation under
the Israeli tax laws.
December 31
25%
FUND
LIFE(TERM):
MINIMUM
PURCHASE:
OFFERING &
ORGANISATION
EXPENSES:
TAXATION:
FISCAL YEAR
END:
CARRIED
INTEREST:
2017
FUND STRUCTURE
PARNASA 61 – Biomedical Fund
18. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Eliezer Gross,
Founder and Chairman
With over 30 years of experience launching business
ventures in Israel, the United States, and Europe. He was a
founding partner of the American GBM Group, and of the
largest retail chains in Israel. Active in dozens of startup
initiatives and companies worldwide, he knows the U.S
market inside and out and has been influential in developing
many new products.
His keen business acumen has led him through the doors of
dozens of leading companies – primarily from the Fortune
100 including: Johnson & Johnson Corporation, CBS Studios,
Goodyear Tires, et al.
19. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Cobi Bitton
CEO, Besadno Group
Mr. Bitton is an entrepreneur, organizational consultant, and
expert in business development and the study of entrepreneurial
business models. He holds a Bachelor's degree in Industrial and
Management, an MBA and is highly knowledgeable about
conventional industrial production, environmental issues, and
safety and security products.
He was one of the entrepreneurs and founders of the SEC (Safe
Evacuation Coalition) - an advocacy group formed by companies,
and dedicated to promoting advanced emergency means of
egress solutions in the global market.
He has been counseling businesses, entrepreneurs, startups and
corporations for the past 25 years, empowering clients in the
American, Eastern and Central European, Latin, Russian, and
East Asian markets, among other locations. Cobi serves as the
CEO of Israel - Greece Chamber of Commerce, voluntarily.
20. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Gabby Hasson
CEO, Bseed Investments
Gabby is the CEO and Co-Founder of Bseed Investments,
with over 25 years of proven experience in the Investment,
IT and cutting-edge technology space in navigating and
uncovering opportunities for excellent growth and
profitability.
Previously, Gabby held management, Investment, and
business development positions, at CB Alliance (VC), IBM,
and HP, as well as Mashik Consulting and CTI. He
specialized in uncovering and enhancing solutions for
Mobile Telecom, Banking, and Online Marketing. Gabby
gained vast experience with IBM's Global Technology Unit
(GTU), that focused on startups and innovations.
21. MANAGEMENT TEAM
2017
MANAGEMENT TEAM
PARNASA 61 – Biomedical Fund
Mr. Eliashiv (LLB) is the Head of Development in the
Besadno Group. Oded has vast experience in the
Israeli startup industry, having led numerous ventures
in leading companies including Excellence Capital
Group (Singapore), Excellence AgriTech Solutions
(Cambodia), Slyde, ElectroPep, Beyond Interactive and
Epos Technologies.
Using his extensive experience in the startup
ecosystem, Oded is now advising early-stage startups
and providing them with the mentoring and fundraising
assistance.Oded Eliashiv
Head of Development,
Besadno Group